| Pembrolizumab in combination with pomalidomide and dexamethasone (PEMBRO/POM/DEX) for pomalidomide exposed relapsed or refractory multiple myeloma L Wilson, AD Cohen, BM Weiss, DT Vogl, AL Garfall, DL Capozzi, ... Blood 128 (22), 2119, 2016 | 17 | 2016 |
| Circulating multiple myeloma cells (CMMCs): a novel method for detection and molecular characterization of peripheral blood plasma cells in multiple myeloma precursor states B Weiss, K Sasser, C Rao, B Foulk, S Gross, G Mallon, C Erb, A Berkowitz, ... Blood, The Journal of the American Society of Hematology 124 (21), 2031-2031, 2014 | 5 | 2014 |
| Management of the Complications of Hematologic Malignancy and Treatment CH Erb, WH Vogel Hematologic Malignancies in Adults, 537-648, 2014 | 4 | 2014 |
| Infectious Complications Following Venetoclax-Proteasome Inhibitor Based Regimens in Relapsed Myeloma: A Single Center Retrospective Analysis CT Sauter, LL Bernabei, A Waxman, AD Cohen, AL Garfall, DT Vogl, ... Blood 134, 5598, 2019 | | 2019 |
| Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis L Bernabei, C Sauter, A Waxman, A Cohen, A Garfall, DT Vogl, C Erb, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e124-e125, 2019 | | 2019 |
| Correlation of Antibody Screens with Clinical Response to Daratumumab Therapy in Multiple Myeloma Patients J Hawkins, R Thomas, M Herwig, R Davis-Rauser, CH Erb, AC Barron, ... 2017 AABB Annual Meeting, 2017 | | 2017 |
| Outcomes of Salvage Second Autologous Stem Cell Transplantation for Relapsed/Refractory Multiple Myeloma in the Era of Modern Therapy EC Ayers, DT Vogl, AD Cohen, BM Weiss, K Cunningham, P Mangan, ... Biology of Blood and Marrow Transplantation 23 (3), S262-S263, 2017 | | 2017 |
| Brentuximab Vedotin for the Treatment of Relapsed/Refractory HL and ALCL C Erb | | |
